TransMedics (TMDX) Net Cash Flow Growth (1y) (2019 - 2026)
TransMedics (TMDX) Net Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 76.43% |
| 10 | TransMedics | 2.51 Bn | 2.05 Bn | 101.16 Mn | 68.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.87% |
| Dec 31, 2025 | 205.09% |
| Sep 30, 2025 | 298.50% |
| Jun 30, 2025 | 611.52% |
| Mar 31, 2025 | 39.52% |
| Dec 31, 2024 | 122.22% |
| Sep 30, 2024 | 78.71% |
| Jun 30, 2024 | -96.74% |
| Mar 31, 2024 | -689.02% |
| Dec 31, 2023 | -772.79% |
| Sep 30, 2023 | -188.83% |
| Jun 30, 2023 | 2,839.88% |
| Mar 31, 2023 | 24.80% |
| Dec 31, 2022 | -210.18% |
| Sep 30, 2022 | 6,821.28% |
| Jun 30, 2022 | 966.23% |
| Mar 31, 2022 | -396.51% |
| Dec 31, 2021 | 21.95% |
| Sep 30, 2021 | 91.36% |
| Jun 30, 2021 | -105.78% |